facebook


Go ProSubmit a deal
Submit
Home

/

Deals

/

National

/

All

/

Raise

/

Vesalius Longevity Labs Sec...

Updated Nov 19, 2026

Vesalius Longevity Labs Secures $25 Million To Expand Global Market Presence
RAISERaise

Vesalius Longevity Labs Secures $25 Million To Expand Global Market Presence

Building Size

—

Asset Type

—

Closing

Nov 16, 2026

About this deal

AI

Vesalius Longevity Labs raised $25 million to enhance its longevity and regenerative health platform, which focuses on peptides, biologics, and preventative healthcare. The capital will assist in expanding its sales team, entering new global markets, and meeting the demand for safe, regulated access to longevity therapies.

Summary of transaction details:

Founded by James McRoberts, Vesalius Longevity Labs operates a proprietary ecosystem that connects healthcare providers with compliant pharmacies, enabling access to therapies, education, and partnerships. The company plans to manufacture its own Peptual® “Made-in-the-USA” peptide APIs for distribution to compounding pharmacies both domestically and internationally.

Instagram

Players

David Adelman

Vesalius Longevity Labs

Buyer

1 deal

Buyer

Market CRE Market Snapshot

Boundary boundary · CRE · Raise transactions

Loading comparables…

Deal FAQ

Visit David Adelman to view all their deals.

Browse this market sales on Traded.

Purchase Price

Annual NOI

Loan Amount

Interest Rate (%)

Loan Term (yrs)

Down Payment (%)

Cap Rate

5.80%

Cash-on-Cash

-1.66%

Monthly Payment

$14,164

Annual Debt Svc

$169,964

Annual Cash Flow

$-11,334

DSCR

0.93

More Deals